Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sparsha Pharma Usa Inc
FDA Inspection
•Sparsha Pharma Usa Inc•September 4, 2025

Sparsha Pharma Usa Inc – FDA Inspection, Sep 4, 2025

Record Details

This FDA Inspection record concerns Sparsha Pharma Usa Inc, with an inspection on September 4, 2025, issued by the Los Angeles District Office, covering human drugs.

Company
Sparsha Pharma Usa Inc
Inspection Date
September 4, 2025
Product Type
Human Drugs
Office
Los Angeles District Office
People
  • Cecilia H. Kieu (FDA Associated Person)
  • Crystal Monroy
  • Joey V. Quitania (FDA Associated Person)
  • Katherine E. Jacobitz (FDA Associated Person)
  • Navneet Kaur (Investigator)
View Company Profile

ID · 4c28f907-5cd5-405c-a8ca-e5fbd00313fb

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1280450
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

10
  1. 21 CFR 211.160(a)Lab controls established, including changes
  2. 21 CFR 211.165(e)Test methods
  3. 21 CFR 820.20(b)Lack of or inadequate organizational structure
  4. 21 CFR 820.100(b)Documentation
  5. 21 CFR 211.142Written warehousing procedures established/followed
  6. 21 CFR 211.68(b)Computer control of master formula records
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.160(b)(2)Acceptance of in-process materials
  9. 21 CFR 211.194(a)Complete test data included in records
  10. 21 CFR 211.188(b)(7)Documentation of Actual Yield and Theoretical Yield

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sparsha Pharma Usa Inc

2
DateClassificationOfficeProject area
September 3, 2026Not classifiedLos Angeles District OfficeGeneric Drug Evaluation
April 28, 2017OAICenter for Devices and Radiological HealthCompliance: Devices
Other documents for Sparsha Pharma Usa Inc
  • FDA Inspection 1334198 - 2026-09-03
  • FDA Inspection 1010514 - 2017-04-28

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sparsha Pharma Usa Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.